Abstract
Intensity-modulated radiation therapy (IMRT) is becoming increasingly popular in the treatment of gynecologic cancers, particularly in patients with cervical and endometrial cancers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mell LK, Mundt AJ (2005) Survey of IMRT use in the United States, 2004. Cancer 104:1296–1303
Mell LK, Mundt AJ (2008) IMRT in gynecologic cancers: growing support, growing acceptance. Cancer J 14:198–199
Yang R, Xu S, Jiang W et al (2010) Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy. Acta Oncol 49:230–236
Heron DE, Gerszten K, Selvaraj RN et al (2003) Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. Gynecol Oncol 91:39–45
Bouchard M, Nadeau S, Gingras L et al (2008) Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 71:1343–1350
Beriwal S, Jain SK, Heron DE et al (2006) Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy. Gynecol Oncol 102:195–199
Mundt AJ, Mell LK, Roeske JC (2003) Preliminary analysis of chronic gastrointestinal toxicity in patients with gynecologic malignancies treated with intensity modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56:1354–1360
Small W Jr, Mell LK, Anderson P et al (2008) Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 71:428–434
Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744–751
Naumann RW, Coleman RL (2007) The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005. Gynecol Oncol 105:7–11
Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority randomised trial. Lancet 375:816–820
Mell LK, Kochanski JD, Roeske JC et al (2006) Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 66:1356–1365
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mundt, A.J., Yashar, C., Mell, L.K. (2013). Endometrial Cancer. In: Lee, N., Lu, J. (eds) Target Volume Delineation and Field Setup. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28860-9_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-28860-9_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28859-3
Online ISBN: 978-3-642-28860-9
eBook Packages: MedicineMedicine (R0)